Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Pharmacology|September 11, 2019
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug TransferAndré Dallmann, Xiaomei I Liu, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics|July 25, 2025
Pediatric Hepatic Impairment Dosing in FDA Approvals Between 2002 and 2024Deandra A Cassel, Gilbert J Burckart, Martina D Sahre, et al.
Journal of Clinical Pharmacology|June 29, 2021
Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age GroupsXiaomei I Liu, John N van den Anker, Gilbert J Burckart, et al.
Frontiers in Pediatrics|August 12, 2021
Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology ModelingDionna J Green, Kyunghun Park, Varsha Bhatt-Mehta, et al.
Journal of Clinical Pharmacology|September 15, 2022
A Tribute to the Pioneers of Fetal PharmacologyVarsha Bhatt-Mehta, Robert M Ward, Anne Zajicek, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and ImmunogenicityJian Wang, Hoi-Kei Lon, Shwu-Luan Lee, et al.
Clinical Pharmacokinetics|September 7, 2016
Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and InfantsPeng Duan, Jeffrey W Fisher, Kenta Yoshida, et al.
Therapeutic Innovation & Regulatory Science|September 9, 2020
Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and PerspectivesJeremiah D Momper, Dionna J Green, Kyunghun Park, et al.
Therapeutic Innovation & Regulatory Science|October 25, 2016
Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug DevelopmentAnn W McMahon, Kevin Watt, Jian Wang, et al.
Journal of Clinical Pharmacology|February 4, 2022
Pediatric and Adult Placebo Response Rates in Placebo-Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012-2020Kyunghun Park, Ngan K Tran, Jeremiah D Momper, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacology|September 11, 2019
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug TransferAndré Dallmann, Xiaomei I Liu, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics|July 25, 2025
Pediatric Hepatic Impairment Dosing in FDA Approvals Between 2002 and 2024Deandra A Cassel, Gilbert J Burckart, Martina D Sahre, et al.
Journal of Clinical Pharmacology|June 29, 2021
Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age GroupsXiaomei I Liu, John N van den Anker, Gilbert J Burckart, et al.
Frontiers in Pediatrics|August 12, 2021
Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology ModelingDionna J Green, Kyunghun Park, Varsha Bhatt-Mehta, et al.
Journal of Clinical Pharmacology|September 15, 2022
A Tribute to the Pioneers of Fetal PharmacologyVarsha Bhatt-Mehta, Robert M Ward, Anne Zajicek, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and ImmunogenicityJian Wang, Hoi-Kei Lon, Shwu-Luan Lee, et al.
Clinical Pharmacokinetics|September 7, 2016
Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and InfantsPeng Duan, Jeffrey W Fisher, Kenta Yoshida, et al.
Therapeutic Innovation & Regulatory Science|September 9, 2020
Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and PerspectivesJeremiah D Momper, Dionna J Green, Kyunghun Park, et al.
Therapeutic Innovation & Regulatory Science|October 25, 2016
Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug DevelopmentAnn W McMahon, Kevin Watt, Jian Wang, et al.
Journal of Clinical Pharmacology|February 4, 2022
Pediatric and Adult Placebo Response Rates in Placebo-Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012-2020Kyunghun Park, Ngan K Tran, Jeremiah D Momper, et al.
Pageof 13